C
CVS icon

Covestor’s CVS Health CVS Stock Holding History

Covestor’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35K Sell
486
-185
-28% -$14.3K 0.02% 888
2025
Q4 		$53K Sell
671
-53
-7% -$4.18K 0.03% 890
2025
Q3 		$55K Sell
724
-24
-3% -$1.65K 0.03% 861
2025
Q2 		$52K Sell
748
-214
-22% -$14K 0.03% 876
2025
Q1 		$65K Sell
962
-24
-2% -$1.44K 0.04% 724
2024
Q4 		$44K Sell
986
-22
-2% -$1.23K 0.03% 906
2024
Q3 		$63K Buy
1,008
+37
+4% +$2.16K 0.04% 776
2024
Q2 		$58K Buy
971
+200
+26% +$12.5K 0.04% 786
2024
Q1 		$62K Sell
771
-96
-11% -$7.33K 0.04% 792
2023
Q4 		$68K Buy
867
+37
+4% +$2.63K 0.05% 710
2023
Q3 		$58K Sell
830
-49
-6% -$3.47K 0.04% 695
2023
Q2 		$61K Sell
879
-155
-15% -$11K 0.05% 695
2023
Q1 		$77K Sell
1,034
-194
-16% -$16.3K 0.07% 522
2022
Q4 		$115K Sell
1,228
-116
-9% -$11.2K 0.09% 326
2022
Q3 		$128K Sell
1,344
-1,712
-56% -$169K 0.11% 233
2022
Q2 		$283K Sell
3,056
-76
-2% -$7.42K 0.22% 57
2022
Q1 		$317K Buy
3,132
+1,634
+109% +$172K 0.21% 57
2021
Q4 		$155K Buy
+1,498
New +$138K 0.22% 50

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Covestor's CVS Position: Q1 2026 in Review

Covestor reduced its CVS Health (CVS) stake by 28% in Q1 2026, selling an estimated $14.3K and leaving 486 shares worth $35K. The position accounts for 0.02% of the portfolio, ranked #888.

Covestor first reported a position in CVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $317K in Q1 2022. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Covestor held 486 shares of CVS Health worth $35K as of Q1 2026.
  • Covestor sold 185 CVS Health shares in Q1 2026, an estimated $14.3K.
  • CVS Health made up 0.02% of Covestor's portfolio in Q1 2026, its #888 holding.
  • Covestor first reported a position in CVS Health in Q4 2021 and has held it in 18 quarters since.
  • Covestor's CVS Health position peaked at $317K in Q1 2022.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.